The TT genotype of methylenetetrahydrofolate reductase 677C>T polymorphism increases the susceptibility to pediatric ischemic stroke: meta-analysis of the 822 cases and 1,552 controls by Sarecka-Hujar, Beata et al.
The TT genotype of methylenetetrahydrofolate reductase 677C>T
polymorphism increases the susceptibility to pediatric ischemic
stroke: meta-analysis of the 822 cases and 1,552 controls
Beata Sarecka-Hujar • Ilona Kopyta •
Karolina Pienczk-Reclawowicz • Daniel Reclawowicz •
Ewa Emich-Widera • Ewa Pilarska
Received: 20 November 2011/Accepted: 16 April 2012/Published online: 4 May 2012
 The Author(s) 2012. This article is published with open access at Springerlink.com
Abstract The 677C[T polymorphism within methyle-
netetrahydrofolate reductase (MTHFR) gene is related to an
elevated level of homocysteine. Thus it may be considered
as a genetic risk factor in ischemic stroke. Apparently
studies of this type of polymorphism in childhood stroke
have shown conﬂicting results. We performed meta-anal-
ysis of all the data that are available in relation with
MTHFR polymorphism and the risk of ischemic stroke in
children. We searched PubMed (last search dated Decem-
ber 2010) using ‘‘MTHFR polymorphism’’, ‘‘ischemic
stroke’’ ‘‘child’’, ‘‘children’’, ‘‘pediatric stroke’’ as key-
words and reference lists of studies and reviews on the
topic. Finally, 15 case–control studies corresponded to the
inclusion criteria for meta-analysis. These studies involved
the total number of 822 children and adolescents after
ischemic stroke and 1,552 control subjects. Fixed or ran-
dom effects models were used depending on the hetero-
geneity between the studies. The association between
ischemic stroke and 677C[T polymorphism within
MTHFR gene was observed in three of the studies. The
pooled analysis showed that TT genotype of MTHFR gene
is more common in stroke patients than in controls
(p = 0.0402, odds ratio = 1.57, 95 % conﬁdence interval
1.02–2.41). The Egger’s test did not reveal presence of a
publication bias. The results based on a sizeable group of
cases and controls have proved that the 677C[T poly-
morphism in MTHFR gene is associated with the devel-
opment of ischemic stroke in children.
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Introduction
Ischemic stroke is a relatively rare disease in children. The
incidence of the disease comes to about 3 children per
100,000 children per year [1, 2]. Data from family studies
and twin studies suggest that genetic risk factors play an
important role in the pathogenesis of ischemic stroke [3, 4].
Stroke is a multifactorial disease that may result from
interactions between many risk factors: genetic and non-
genetic, as well as environmental ones. Rates of recurrence,
mortality and neurological deﬁcits in pediatric stroke
patients are signiﬁcant and concern more than two thirds of
the affected children [5]. Neurological deﬁcits and post-
stroke disability place a heavy burden on the societies.
Case–control approaches are currently being widely used
to determine risk factors in ischemic stroke in adults and
children. The 677C[T polymorphism in methylenetetrahy-
drofolate reductase (MTHFR) gene is one of the most
extensivelyinvestigated candidatepolymorphisms.MTHFR
catalysesthereductionof5,10-methylenetetrahydrofolateto
5-methylenetetrahydrofolate, which is the main form of
folate in plasma and a carbon donor for the remethylation of
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(677C[T) transition in the MTHFR gene inﬂuences enzyme
thermolability, its decreased activity and, in turn, the ele-
vated level of homocysteine. Thus the MTHFR polymor-
phism is suggested to be a genetic risk factor in
cerebrovascular diseases, including ischemic stroke [7].
As mentioned earlier, studies of this variant in childhood
stroke have revealed conﬂicting results. Some of the reports
have showed the relation between MTHFR 677C[T poly-
morphism and stroke in children [8–10], while other studies
have not indicated such correlations [11, 12]. This may be
due to the heterogenic character of this type of stroke as
different groups of patients may have various sets of genetic
factors which predispose to the disease. Some alleles of
candidate genes may be strongly associated with the disease
inonepopulation,whereasinanotherthiscorrelationmaybe
weak due to the presence of other genetic factors or speciﬁc
interactions between genetic and non-genetic factors.
Meta-analysis is a method that enables pooling data
from smaller inconclusive studies and yields it with a
greater statistical power and allows one to quantify genetic
risks more precisely.
We performed meta-analysis of all the data that has been
published so far in relation to the risk of ischemic stroke in
children with the MTHFR 677C[T polymorphism. We
aimed to describe the association between TT genotype of
MTHFR gene and the risk of childhood ischemic stroke by
meta-analysis.
Methods
Data acquisition
In the ﬁrst place we identiﬁed all articles published before
December 2010 on the MTHFR 677C[T polymorphism and
its association with ischemic stroke in pediatric patients.
Two independent investigators searched the literature using
PubMed (last search December 2010). All the references
cited in the found studies were also reviewed in order to ﬁnd
other published articles that had been indexed by PubMed.
The language was limited to English. The key words used
for this search were: ‘‘MTHFR polymorphism’’, ‘‘ischemic
stroke’’, ‘‘child’’, ‘‘children’’, ‘‘pediatric stroke’’. Abstracts
were not included in the search. The inclusion criteria were
as follows: (a) a case–control study, (b) study population or
at least a subgroup comprising children (between birth and
puberty, till 12 ages) and adolescents (between the ages of
13 and 19); in some studies this population included neo-
nates and perinatal stroke patients (c) conﬁrmed ischemic
stroke with magnetic resonance imaging (MRI) or computer
tomography (CT). A given study was excluded from this
meta-analysis when: (a) genotype or allele frequencies were
not reported, (b) study design was other than case–control,
(c) the associations between MTHFR polymorphism and
stroke in adults were investigated, (d) outcome deﬁnition
was other than ischemic stroke. We attempted to contact the
authors of the found reports to get additional data. In case of
lack of relevant data or response from the author of a par-
ticular work, the study was excluded. Unavailability of data
or failure to answer (after repeated attempts) resulted in the
exclusion of the study. Of the found publications, 15 studies
published during the period from 1998 to 2009 satisfy the
inclusion criteria [8–22], including our previously pub-
lished data [8]. Three of the articles found in PubMed were
not included in the meta-analysis because of the overlap of
the patients group in other publications [23–25]. We also
excluded one publication because the age of the analyzed
population ranged from 7 to 36 years [26]. No subgroup
containing pediatric population was distinguished so we
decided not to the analyze entire data. Data from 15 pub-
lished studies were included in meta-analysis, comprisingin
total 822 cases and 1,552 controls.
The meta-analysis was performed in accordance with
the Meta-analysis Of Observational Studies in Epidemiol-
ogy (MOOSE) guidelines [27].
Statistical analyses
ThedatawereanalyzedbymeansoftheMIX1.7software[28,
29].Todeterminethestrengthbetweengeneticpolymorphism
and childhood ischemic stroke pooled odds ratio (OR) was
calculated together with 95 % conﬁdence intervals (CI).
Heterogeneity between the studies was evaluated using the
Dersimonian and Laird’s Q test. If the p value was less than
0.05, the heterogeneity was considered statistically signiﬁ-
cant. The I
2 metric describes the percentage of the observed
between-study variability due to heterogeneity rather than
samplingerrorandwasusedtoquantifyheterogeneity.TheI
2
values ranged between 0 and 100 %, with higher values
indicating a greater degree of heterogeneity. In case of sig-
niﬁcant heterogeneity observed between the studies, the
pooled OR was estimated using a random effects model,
otherwiseaﬁxedeffectsmodelwasused.Publicationbiaswas
examined with the Egger’s regression asymmetry test.
Results
Characteristics of the included studies
Thirteen of the analyzed studies involved less than one
hundred pediatric stroke patients. The largest group was
analyzed by Nowak-Go ¨ttl et al. [19], the least group of cases
was studied by Morita et al. [13]. The highest distributions of
the TT genotype in the patients’ groups were observed by
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123Cardo et al. [18]—29 %, Morita et al. [13]—26 % and No-
wak-Go ¨ttl et al. [19]—24 %. Frequency of the TT homo-
zygotes among controls was the highest in the studies of
Rook et al. [11]—19 %, Komitopoulou et al. [17]—17 %
andKenetetal.[10]—15 %.Additionally,inone publication
analysis of the families (both of the parents and their affected
offspring)was performed except for a case–control study [8].
Characteristics of individuals included to this meta-
analysis is shown in Table 1.
A total number of 2,374 individuals were involved in
this meta-analysis, including 822 children and adolescents
after ischemic stroke and 1,552 control subjects. In all of
the 15 studies, different racial populations were analyzed,
however Caucasians were the most common.
The association between 677C[T polymorphism within
MTHFR gene was observed in three of the analyzed studies
[8, 9, 19]. The strongest relationship between MTHFR
polymorphism and childhood ischemic stroke was observed
byBiswasetal.[9]althoughtheresultconcernedsynergistic
effect between HPA-1 and MTHFR polymorphisms. The
other of the included studies showed no relations between
MTHFR polymorphism and ischemic stroke in childhood
[10–18, 20–22] (Table 1).
MTHFR polymorphism and childhood stroke
Summary frequencies of MTHFR genotypes and alleles
from all the studies included in the meta-analysis are pre-
sented in Table 1.
There was signiﬁcant heterogeneity between the ana-
lyzed studies observed for the following analyses:
I
2 = 47.4 %, p = 0.025 in case of TT versus CC ? CT
analysis and therefore random effects model with Dersi-
monian Laird test was used to analyze this combination.
The pooled analysis showed that TT genotype of
MTHFR gene is more common in stroke patients than in
controls when compared to CC ? CT genotypes
(p = 0.0402, OR = 1.57, 95 % CI 1.02–2.41) (Fig. 1). For
the MTHFR gene polymorphism, the Egger’s test did not
reveal presence of a publication bias (z = 0.22, p value
(two-tailed) = 0.825).
Additionally, in 11 of the studies we calculated associ-
ation between carriers of MTHFR T allele (subjects with
CT ? TT genotypes) and wild-type homozygous. The
pooled analysis showed that carriers of T allele are more
common in stroke patients than in controls when compared
to individuals with CC genotypes (p = 0.014, OR = 1.52,
95 % CI 1.09–2.12) (Fig. 2).
Sensitivity analysis
According to our calculation, distribution of the MTHFR
genotypes in controls differed from Hardy–Weinberg
equilibrium (HWE) in one of the analyzed studies, what
suggested possible genotyping errors or population bias
(v
2 = 4.033, p = 0.045), although the result was close to
the bound of signiﬁcance. Exclusion of this study did not
Table 1 Characteristics of studies included to the meta-analysis
Cases Controls p
a OR
a (95 % CI)
a
N Age %
Male
CC CT TT N Age %
Male
CC CT TT
Zak et al., Poland 2009 [8] 64 8.7 ± 5.7 54.7 25 30 9 59 9.0 ± 5.9 64.4 32 25 2 0.058 1.49 (0.99–2.24)
Biswas et al., India 2009 [9]5 8 \15 – 24 32 2 58 \15 – 48 10 0 \0.001 –
Kenet et al., Israel 2000 [10] 58 7.2 ± 6.5 51.7 50 8 118 9.3 ± 5.9 65.5 100 18 – 1.06 (0.40–2.70)
Rook et al., Canada 2005 [11] 33 4.2 45.5 17 12 4 21 – – 9 8 4 0.10 –
Djordjevic et al., Serbia 2009 [12] 26 8.5 ± 5.1 57.7 9 16 1 50 6.5 ± 4.1 52 23 22 5 0.66 0.36 (0.05–3.25)
Morita et al., USA 2009 [13] 15 – – 5 6 4 90 – – 48 37 5 – 1.06 (0.22–4.00)
Sirachainan et al., Thailand 2008 [14]4 6 \18 – 33 13 0 161 \18 – 117 44 0 0.90 1.10 (0.50–2.20)
Akar et al., Turkey 1999 [15]2 8 \18 – 14 10 4 106 – – 63 37 6 – 3.9 (0.75–12.10)
Herak et al., Croatia 2009 [16]5 9 \16 64.4 20 30 9 112 9.8 ± 4.3 69.9 46 56 10 0.333 1.82 (0.58–5.77)
Komitopoulou et al., Greece 2006 [17] 90 5.5 ± 4.8 – 36 46 8 103 3.9 ± 4.0 – 46 39 18 0.094 1.20 (0.70–2.10)
Cardo et al., Spain 2000 [18]2 1 \18 – 6 9 6 28 – – 7 17 4 ND ND ND
Nowak-Go ¨ttl et al., Germany 1999
[19]
148 0.5–16 47 113 35 296 0.5–16 47 265 31 \0.0001, 2.60 (1.53–4.50)
Barreirinho et al., Portugal 2003 [20] 21 5.3 – 9 11 1 114 – – 55 46 13 0.298 0.37 (0.05–2.98)
Prengler et al., UK 2001 [21] 118 0.5–17 – 96 22 78 – – 69 9 – 1.80 (0.76–4.00)
McColl et al., UK 1999 [22]3 7 \15 – 30 7 158 – – 139 19 – 1.70 (0.60–4.50)
Summary 822 120 1,552 144
OR odds ratio, CI conﬁdence interval, ND non-detectable due to low number of cases and controls
a Data from included publications
Mol Biol Rep (2012) 39:7957–7963 7959
123alter the results, thus suggested stability of the present
meta-analysis.
Discussion
In the present study we investigate association between
677C[T polymorphism in MTHFR gene and ischemic
stroke in children. Data concerning relations between
genetic risk factors and pediatric stroke are scarce in
comparison to adult stroke analyses. In some pediatric
patients the etiology of stroke is not fully understood,
however, we may, as it was previously suggested, attribute
it to the signiﬁcant role a genetic factor may play in the
development of ischemic stroke [4]. The MTHFR 677C[T
polymorphism may be related to higher levels of
Exposed
n[e](E=1)/n[e]
Control
n[c](E=1)/n[c]
Weight
(%)
Association measure
with 95% CI
Year Study ID
Zak et al, [8] 2009 9/64 2/59 5,21% | 4,6636 (0,9641  to  22,5587)
Biswas et al, [9] 2009 2/58 0/58 1,77% | 5,177 (0,2432  to  110,2243)
Kenet et al, [10] 2000 8/58 18/118 9,86% | 0,8889 (0,3616  to  2,1849)
Rook et al, [11] 2005 4/33 4/21 5,53% | 0,5862 (0,1295  to  2,6528)
Djordjevic et al, [12] 2009 1/26 5/50 3,13% | 0,36 (0,0398  to  3,2555)
Morita et al, [13] 2009 4/15 5/90 5,80% | 6,1818 (1,4398  to  26,541)
Akar et al, [15] 1999 4/28 6/106 6,45% | 2,7778 (0,7264  to  10,6222)
Herak et al, [16] 2009 9/59 10/112 9,29% | 1,836 (0,7016  to  4,8047)
Komitopoulou et al, [17] 2006 8/90 18/103 9,99% | 0,4607 (0,1899  to  1,1178)
Cardo et al, [18] 2000 6/21 4/28 6,00% | 2,4 (0,58  to  9,9304)
Nowak-Gottl et al, [19]  1999 35/148 31/296 13,72% ||| | 2,6477 (1,5566  to  4,5037)
Barreirinho et al, [20] 2003 1/21 13/114 3,40% | 0,3885 (0,0481  to  3,1399)
Prengler et al, [21] 2001 22/118 9/78 10,49% ||| | 1,7569 (0,7623  to  4,0492)
McColl et al, [22] 1999 7/37 19/158 9,37% | 1,707 (0,6587  to  4,4235)
META-ANALYSIS: 120/776 144/1391 100% |||||| ||||||| |||||||| ||||||| | 1,5683 (1,0203 to 2,4106)
0,01 0,1 1 10 100 1000
OR (log scale)
S
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Fig. 1 Meta-analysis of association between TT genotype of MTHFR
gene and pediatric ischemic stroke. OR and 95 % CI of the TT
genotype versus CC ? CT were calculated from data presented in
individual studies. A random effects model with the method of
Dersimonian Laird was used to calculate pooled weighted OR. One
study was excluded from the calculation because of the lack of TT
genotype, both in cases and controls [14]
Exposed
n[e](E=1)/n[e]
Control
n[c](E=1)/n[c]
Weight
(%)
Association measure
with 95%CI
Year StudyID
Zak et al, [8] 2009 39/64 27/59 11,11% |||| 1,8489 (0,9024  to  3,7881)
Biswas et al, [9] 2009 34/58 10/58 9,09% | 6,8 (2,8815  to  16,0473)
Rook et al, [11] 2005 16/33 12/21 6,55% | 0,7059 (0,2346  to  2,1235)
Djordjevic et al, [12] 2009 17/26 27/50 7,68% | 1,6091 (0,6034  to  4,291)
Morita et al, [13] 2009 10/15 42/90 6,15% | 2,2857 (0,7233  to  7,2232)
Sirachainan et al.. [14] 2008 13/46 44/161 10,92% |||| 1,0475 (0,5051  to  2,1724)
Akar et al, [15] 1999 14/28 43/106 9,38% | 1,4651 (0,635  to  3,3806)
Herak et al, [16] 2009 39/59 66/112 12,10% |||| 1,3591 (0,7042  to  2,623)
Komitopoulou et al, [17] 2006 54/90 57/103 13,63% |||| 1,2105 (0,6823  to  2,1478)
Cardo et al, [18] 2000 15/21 21/28 5,26% | 0,8333 (0,2326  to  2,9851)
Barreirinho et al, [20] 2003 12/21 59/114 8,13% | 1,2429 (0,486  to  3,179)
META-ANALYSIS: 263/461 408/902 100% ||||||||||||||| ||||||||||||| | 1,5208 (1,0892 to 2,1234)
0,1 1 10 100
OR (log scale)
S
t
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Fig. 2 Meta-analysis of association between carriers of T allele
(individuals with CT ? TT genotypes) of MTHFR gene and pediatric
ischemic stroke. OR and 95 % CI of the CT ? TT genotypes versus
CC were calculated from data presented in individual studies. A
random effects model with the method of Dersimonian Laird was
used to calculate pooled weighted OR. Four of the studies were
excluded from the calculation due to lack of accurate data of CT
genotype, both in cases and controls [10, 19, 21, 22]
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123homocysteine and in consequence to a higher stroke risk [6,
7, 30]. According to Fowler [31] the homozygous variant
of MTHFR gene is present in 5–18 % of the population.
Hyperhomocysteinemia may consequently lead to endo-
thelial dysfunction of arteries, an early step in the devel-
opment of atherosclerosis [7]. Homocysteine also
stimulates elevation of superoxide anion, platelet aggre-
gation and decreases nitric oxide bioavailability [32]. Thus
elevated homocysteine is an established risk factor in
venous and arterial thrombosis although there are some
discrepancies on association between MTHFR polymor-
phism and the increased level of HCys. Some studies
indicate such relations with Hcys levels elevated over 25 %
in TT individuals compared to subjects with CC genotype
[6]. It was also demonstrated, in a general population, that
individuals with TT genotype and a low plasma folate level
or a low folate intake, had higher total plasma homocys-
teine concentrations than subjects with CT and CC geno-
types [33]. On the other hand, Alsayouf et al. [34] found no
relation between TT genotype and homocysteine concen-
tration and observed minimal role of 677C[T polymor-
phism and stroke in children. According to Unal et al. [35]
MTHFR polymorphism analyzed alone, without level of
homocysteine, had no important role in pediatric ischemic
stroke. Among analyzed studies, the association between
677C[T polymorphism within MTHFR gene was observed
in three reports [8, 9, 19], the rest of the studied data did
not conﬁrm the relation [10–18, 20–22]. These discrepan-
cies may be mainly due to a low number of patients in the
analyzed groups.
Under these controversial results, we decided to perform
meta-analysis based on a larger group of cases and controls
than in single studies to estimate whether there is any
relation between TT homozygous state and pediatric
ischemic stroke.
Results obtained from the analyzed group of cases and
controls conﬁrmed that TT genotype of 677C[T poly-
morphism as well as carrier-state of T allele are associated
with the development of childhood ischemic stroke. Cau-
casians were the most common race among the analyzed
subjects. Racial-ethnic differences in distribution of the
677C[T polymorphism in MTHFR gene have already been
described [36, 37]. Klerk et al. [38] demonstrated that the
association between MTHFR 677C[T polymorphism and
coronary heart disease was weaker in European popula-
tions, than that observed in Asian populations, which might
be partially attributable to the difference in folate intake
between the two ethnic groups.
Earlier studies on MTHFR polymorphism in different
populations yielded equivocal results on associations
betweenMTHFR677C[Tpolymorphismandstroke,bothin
adults and children. McColgan and Sharma [39] found no
relation between MTHFR polymorphism and carotid
dissection, a common cause of stroke in young adults
accounting for 20 % of strokes. Meta-analysis of three can-
didate genes: MTHFR, ACE and APOE in Asian population,
revealed a signiﬁcant association of stroke with the MTHFR
677C[T polymorphism and APOE epsilon 4 alleles, in
contrast to ACE gene insertion/deletion polymorphism [40].
In another study based on about 7,000 stroke patients, a
gradual increase in the ischemic stroke risk with increasing
MTHFR 677T allele dose was observed, which suggests that
MTHFRpolymorphismmayplayasigniﬁcantroleingenetic
susceptibilitytostroke[41].Meta-analysisofseveralstudies
analyzing correlation between MTHFR polymorphism and
levels of Hcys and stroke suggested that MTHFR TT geno-
type may have a small role in determining susceptibility to
ischemic stoke [42]. Kelly et al. [42] have also found cor-
relation between mild-to-moderate hyperhomocysteinemia
andstrokeinthegroupofabout2,500strokepatients.Onthe
other hand Wu and Tsongalis [43] conﬁrmed the association
between the TT homozygous variant of MTHFR gene and
coronary artery disease (CAD) but denied its connections
with the stroke.
Previous data concerning the role of MTHFR polymor-
phismandCADalsoconﬁrmedthefactthatindividualswith
the TT genotype had a signiﬁcantly higher risk of CAD,
particularlyinthesettingoflowfolatestatus[38].Theresults
of meta-analysis carried out by Klerk et al. [38] proved that
impaired folate metabolism, resulting in high homocysteine
levels, is related to an increased risk of CAD. In another
group of patients with CAD it was found that carrier-state of
T allele of MTHFR polymorphism, together with other
polymorphicvariantsofcandidategenesincreasedtheriskof
the disease, especially in women [44]. Another data of
MTHFRpolymorphism onvenous thrombosis demonstrated
thatMTHFRTTgenotypewasassociatedwitha20 %higher
risk ofthe venous thrombosis development than incase ofto
the CC genotype [45].
The present study has some limitations: the largest one
is the variability between populations of the prevalence of
MTHFR TT genotype in controls which ranges from 0 %
[9, 14]t o1 9%[ 11]. Such differences may be due to a
different number of individuals recruited to the analyzed
studies. Previously, Franco et al. [37] showed that 677C[T
polymorphism in MTHFR gene has a signiﬁcantly hetero-
geneous distribution among different ethnic groups and this
may explain geographical or racial differences that are
linked to the risk of cerebrovascular diseases. Another
limitation of our meta-analysis is the fact that in some of
the analyzed data included neonates with stroke which also
became inclusion criterion in the present meta-analysis,
although some publications differentiate neonatal stroke
from childhood stroke [46].
To the best of our knowledge, this is the ﬁrst meta-
analysis concerning relationship between MTHFR
Mol Biol Rep (2012) 39:7957–7963 7961
123polymorphism and the risk of pediatric stroke, including
data from Polish studies. What is more, the present meta-
analysis encompasses over eight hundred children after
ischemic stroke and provides more reliable evidence on the
role of the 677TT genotype in the pathogenesis of pediatric
stroke than scarce data based on small group of patients.
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